Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Cost-effectiveness of mammography, MRI, and ultrasonography for breast cancer screening.

Radiologic clinics of North America - 1 Sept 2010

Feig Stephen

Abstract excerpt

Screening mammography performed annually on all women beginning at age 40 years has reduced breast cancer deaths by 30% to 50%. The cost per year of life saved is well within the range for other commonly accepted medical interventions. Various studies have estimated that reduction in treatment costs through early screening detection may be 30% to 100% or more of the cost of screening. Magnetic resonance imaging...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cost-Benefit Analysis
Share to Diagnostic Imaging
Share to Early Detection of Cancer

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Magnetic Resonance Imaging

Share to Mammography

Share to Mass Screening

Share to Risk Assessment

Share to United States

Source

Identifiers

PMID: 20868891
DOI: 10.1016/j.rcl.2010.06.002

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Cost-effectiveness of mammography, MRI, and ultrasonography for breast cancer screening.PMID 20868891Read ↗

Comparison of costs and benefits of breast cancer screening with mammography, ultrasonography, and MRI.Semantic proximity Read ↗

Cost-effectiveness of screening BRCA1/2 mutation carriers with breast magnetic resonance imaging.Semantic proximity Read ↗

American Cancer Society guidelines for breast screening with MRI as an adjunct to mammography.Semantic proximity Read ↗

Cost-effectiveness of screening women with familial risk for breast cancer with magnetic resonance imaging.Semantic proximity Read ↗

Cost-effectiveness of Breast Cancer Screening With Magnetic Resonance Imaging for Women at Familial Risk.Semantic proximity Read ↗

Breast magnetic resonance imaging for screening high-risk women.Semantic proximity Read ↗

Cost-effectiveness of screening with contrast enhanced magnetic resonance imaging vs X-ray mammography of women at a high familial risk of breast cancer.Semantic proximity Read ↗

Screening of women at high risk for breast cancer.Semantic proximity Read ↗

The added value of mammography in different age-groups of women with and without BRCA mutation screened with breast MRI.Semantic proximity Read ↗

Cost-effectiveness of alternating magnetic resonance imaging and digital mammography screening in BRCA1 and BRCA2 gene mutation carriers.Semantic proximity Read ↗

Cost-effectiveness of MRI for breast cancer screening in BRCA1/2 mutation carriers.Semantic proximity Read ↗

Dynamic contrast-enhanced magnetic resonance imaging for risk-stratified screening in women with BRCA mutations or high familial risk for breast cancer: are we there yet?Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.